Bad Test Used For Pfizer Cancer Drug Patent, Fed. Circ. Told
Mylan urged the Federal Circuit to ax a Delaware federal judge's decision to preserve patents for cancer drug Sutent that Pfizer is asserting against the generics maker, arguing Friday that the...To view the full article, register now.
Already a subscriber? Click here to view full article